FDA Inspection 1255086 — Janssen Vaccines Corp.
The FDA completed an inspection of Janssen Vaccines Corp. on November 19, 2024 in Incheon. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 19, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Incheon (Korea (the Republic of))